Jonathan Chang
Stock Analyst at Leerink Partners
(0)
# 4997
Out of 5,368 analysts
132
Total ratings
22.41%
Success rate
-27.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GMAB Genmab | Upgrades: Outperform | 27 | 22.81 | 18.37% | 10 | Feb 13, 2025 | |
VINC Vincerx Pharma | Maintains: Outperform | 80 40 | n/a | n/a | 6 | Oct 8, 2024 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Outperform | 74 | 34.66 | 113.5% | 1 | Apr 29, 2024 | |
NBTX Nanobiotix | Initiates Coverage On: Outperform | 11 | 5.34 | 105.99% | 1 | Dec 8, 2023 | |
NVCR NovoCure | Initiates Coverage On: Outperform | 51 | 17.54 | 190.76% | 1 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 90 75 | 4.4 | 1604.55% | 12 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 9.78 | 247.65% | 9 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | n/a | n/a | 1 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 18 2 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 40 | n/a | n/a | 6 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 3 2 | n/a | n/a | 7 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 50 | 8.35 | 498.8% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 31 30 | 40.59 | -26.09% | 4 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 12 | 1.52 | 689.47% | 8 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 1 | n/a | n/a | 7 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 13 14 | n/a | n/a | 5 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 26 | 6.14 | 323.45% | 5 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 101 95 | 41.01 | 131.65% | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 20 60 | n/a | n/a | 5 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 2 3 | n/a | n/a | 8 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 4 | n/a | n/a | 5 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 41 28 | 6.43 | 335.46% | 3 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 53 | 9.18 | 477.34% | 7 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 50 0 | n/a | n/a | 2 | May 10, 2018 |